| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, CFO And COO | EVP, CFO | SVP, CFO
1 company
Hyllengren Eric J is an EVP, CFO And COO at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $469K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | ATRA Atara Biotherapeutics, Inc. | EVP, CFO And COO | Sell | 1,211 | $7.00 | $8,473.37 | -2.1% | +14.3% | -22.6% | |
| Nov 18, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, CFO And COO | Sell | 1,364 | $11.20 | $15,274.07 | -5.5% | -28.7% | +18.8% | |
| Aug 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, CFO | Sell | 1,070 | $6.63 | $7,093.09 | -2.1% | +82.2% | +75.3% | |
| May 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, CFO | Sell | 28,648 | $0.62 | $17,675.82 | -4.2% | -48.8% | -54.7% | |
| Mar 4, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, CFO | Sell | 6,679 | $0.72 | $4,810.34 | -0.5% | -23.0% | -62.0% | |
| Nov 16, 2023 | ATRA Atara Biotherapeutics, Inc. | SVP, CFO | Sell | 11,958 | $0.39 | $4,651.66 | -5.5% | +60.3% | -0.1% | |
| Aug 16, 2023 | ATRA Atara Biotherapeutics, Inc. | SVP, CFO | Sell | 8,186 | $1.65 | $13,526.83 | -1.8% | -79.4% | -83.8% | |
| May 16, 2023 | ATRA Atara Biotherapeutics, Inc. | SVP, CFO | Sell | 7,918 | $2.04 | $16,130.69 | -1.7% | -5.3% | -69.2% |